Efficacy and safety of Lianhua Qingwen capsules combined with standard of care in the treatment of adult patients with mild to moderate COVID-19 (FLOSAN): protocol for a randomized, double-blind, international multicenter clinical trial

BACKGROUND: Effective anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drugs are not only the next defense after vaccines but also the key part of establishing a multi-tiered coronavirus disease 2019 (COVID-19) prevention and control system. Previous studies had indicated that Lianh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Yang-Qing, Chen, Rui-Feng, Zheng, Qing-Shan, Li, Xing-Wang, Liu, You-Ning, Mootsikapun, Piroon, Chayakulkeeree, Methee, Arttawejkul, Pureepat, Lan, Truong Thi Ngoc, Liu, Gordon G., Lu, Hong-Zhou, Liu, Qing-Quan, Zhong, Nan-Shan, Yang, Zi-Feng, Zheng, Jin-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267938/
https://www.ncbi.nlm.nih.gov/pubmed/37324081
http://dx.doi.org/10.21037/jtd-23-281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267938/
https://www.ncbi.nlm.nih.gov/pubmed/37324081
http://dx.doi.org/10.21037/jtd-23-281

Ejemplares similares